Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. [electronic resource]
Producer: 20160128Description: 989-96 p. digitalISSN:- 1432-0843
- Acute Kidney Injury -- chemically induced
- Acute-Phase Proteins -- urine
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Agents, Alkylating -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Area Under Curve
- Biomarkers -- urine
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Small Cell -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Chemokine CCL2 -- urine
- Cisplatin -- administration & dosage
- Creatinine -- urine
- Etoposide -- administration & dosage
- Female
- Hepatitis A Virus Cellular Receptor 1
- Humans
- Lipocalin-2
- Lipocalins -- urine
- Lung Neoplasms -- drug therapy
- Male
- Membrane Glycoproteins -- urine
- Middle Aged
- Neoplasm Proteins -- urine
- Proto-Oncogene Proteins -- urine
- ROC Curve
- Receptors, Virus
- Vinblastine -- administration & dosage
- Vinorelbine
- beta 2-Microglobulin -- urine
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.